Research Square

Novel Plasma Proteins Associated With Alzheimer's Disease Risk in APOE ε4 Carriers and Non-carriers

Figure 1. Study design and analytical workflow for genetic risk-stratified plasma proteomics of incident AD
Open the figure at full size
Figure 1. Study design and analytical workflow for genetic risk-stratified plasma proteomics of incident ADStudy design and analytical workflow for genetic risk-stratified plasma proteomics of incident ADLeng et al.
Preprint: cohort study of 18,212 peopleBiomarkers

12.8 years, declared ties to: Signant Health and NovoNordisk

The paper